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ABSTRACT
Organomercury(ll)-purine derivatives of the type, p-MeOC6H,HgL (I), p-NO2C6H4HgCI(L2)
(11), p-MeC6H,HgCI(L3)(III) and p-NO2C6H4HgCI(L3) (IV) [HL theophylline, L2 theobromine, L3
caffeine] have been synthesised and characterised on the basis of spectral studies (IR, UV, H & 3C
NMR). The complexes have been screened for anti-inflammatory activity.
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INTRODUCTION
The purines constitute an important class of anti-inflammatory agents. Important members of
this class include theophylline, theobromine and caffeine. They owe their anti-inflammatory action to
their capacity to affect changes in the basic cellular functions. These compounds act as competitive
inhibitors of phosphodiesterase, an enzyme which inactivates cyclic 3’, 5’-adenosine monophosphate
(3’,5’-c AMP) 1. The enzyme inhibition activates 3’,5’-c AMP, which consequently stimulates
glycoganolysis and promotes cellular processes. It has also been postulated that the purine drugs
act by reducing the binding of calcium in the membrane and myoplasm of the cell, thereby affecting
the contractility of the muscles1.
The interest in the metal complexes of purines has arisen for the following reasons: Firstly,
as a result of antitumor activity of some metal complexes, considerable interest has been shown in
the design of model complexes involving purines which could mimic the interaction of metal ions with
DNA2-4. Secondly, a few metal-purine complexes have shown significant anti-inflammatory activity5.
Thirdly, the investigation of mercury-purine complexes is of particular value, since the known toxic
effects of the organomercury compounds, which are attributed to the formation of mercury-sulphur
bonds with sulphydryl functions in amino acids and proteins, may also be due, in part, to their
interaction with nucleic acid constituents6. Therefore, we have carried out the synthesis of a few
organomercury(ll)-purine complexes and have determined their structure and anti-inflammatory
activity.
EXPERIMENTAL
The following instruments, were used: Elico conductivity bridge model CM-82; Shimadzu
spectrophotometer, IR-435; Perkin-Elmer UV-VIS spectrophotometer, model 554; Jeol FX-200 FT-
NMR spectrometer. Theophylline, theobromine and caffeine were purchased from Sigma Chemical
Co., U.S.A. and used without further purification. The arylmercury(ll) chlorides, p-MeC6H4HgCI, p-
MeOCsH4HgCI and p-NO2CsH4HgCI were synthesised by the method of Nesmeyanov et al7.
Preparation of Complexes. The theophylline complex, p-MeOC6H4HgL was prepared by slowly
adding a solution of p-MeOCeH4HgCI (0.01 tool) in 25 ml DMF to a stirred solution of theophylline
(0.01 tool) in 25 ml DMF at a pH of 8-9. The pH of the solution was set in the desired range by
adding a few drops of 0.1M sodium bicarbonate solution. The contents were stirred for 6h at 50C
and filtered. The filtrate was slowly poured over crushed ice and stirred vigorously. The precipitates
so obtained were washed successively with hot water and benzene. The resulting product was dried
and recrystallized from THF. The theobromine complex, p-NO2CsH4HgCI(L2) and the caffeine
complexes, p-XC6H4HgCI(L3) (X Me, NO2) were synthesised from p-XC6H4HgCI and the respective
purines, by following a similar series of operations, except that the reaction was conducted in a
neutral medium.
Some physico-chemical characteristics of the complexes are as follows:
Dec. temp., 133C.
Anal. Found (Calc.), %: Hg, 41.31 (41.21); C; 34.60 (34.53); N, 11.45 (11.51); H, 2.93 (2.87).
IR (nujol), cm: /(c=0), 1630; y (c=c), 1580; ((c=N), 1530.
UV (DMF), nm (log .) 272 (7.0); 240 (3.1).
H NMR (dS-dmso), 5 3.28 (s,3H,1-Me); 3.48 (s, 3H, 3-Me); 7.10-8.00 (m, 1H, H(8) +
4H(phenyl)); 3.75 (s, 3H, 4’-MeO).
3C NMR (d6-dmso), ppm: Theophyllinato, C(2), 156.8; C(3), 148.5; C(5), 106.3; C(6), 160.3;
C(8), 140.1; 1-Me, 27.3; 3-Me, 30.1; Phenyl, C(1’), 148.8; C(2’,6’), 138.0; C(3’, 5’), 122.0; C(4’),
151.1; 4’-MeO, 20.8.
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(11) Dec. temp., 170C
Anal. Found (Calc.); %: Hg, 37.32 (37.26); C, 28.91 (28.99); N, 13.06 (13.01); CI, 6.65 (6.59);
H, 2.26 (2.23).
IR (nujol) cm1" , (c=0), 1640; /(c=c), 1590; (c=N), 1520; /(Hg-CI), 370.
UV (DMF), nm (log ,):270 (6.2); 240 (3.2).
1H NMR (d6-dmso), 3.40 (t, 3H ,Jl.8Hz,l-Me); 3.92 (s, 3H, 3-Me); 8.20 (s, 1H, H(8)); 7.00-
8.05 (m, 4H (phenyl)).
3C NMR (d6-dmso), ppm: Theobromine, C(2), 152.1; C(4), 148.5; C(5), 107.3; C(6), 160.2;
C(8), 134.5; 3-Me, 30.1; 7-Me, 28.5; Phenyl, C(1 ’), 149.0; C(2,6’), 142.0; C(3’, 5’), 124.5; C(4’),
135.3.
Dec. temp., 212C.
Anal. Found (Calc.), %" Hg, 38.58 (38.48); C, 30.49 (30.43); N, 10.71 (10.74); CI, 6.90 (6.81);
H, 2.46 (2.53).
IR (nujol) cm" (c=0), 1645; , (c=c), 1590; "
(c=N), 1510; , (Hg-CI), 370.
UV (DMF), nm (log ,)" 274 (5.5); 245 (3.0).
H NMR (d-dmso), 5 3.90 (s,3H,1-Me); 3.40 (s, 3H, 3-Me); 3.22 (s, 3H,7-Me); 8.20 (s, 1H,
H(8)); 7.00-7.85 (m, 4H (phenyl)); 2.38 (s, 3H, 4’-Me).
3C NMR (d-dmso), ppm: Caffeine, C(2), 152.2; C(4), 148.5; C(5), 106.8; C(6), 161.1; C(8),
134.5; 1-Me, 26.8; 3-Me, 30.1; 7-Me, 28.5; Phenyl, C(1’), 147.3; C(2’,6’), 151.0; C(3’, 5’),
135.3; C(4’), 156.5; 4’-Me, 21.5.
(IV) Dec. Temp., 235C
Anal. Found (Calc.), %: Hg, 36.30 (36.32); C, 30.47 (30.43); N, 12.73 (12.68); CI, 6.49 (6.43);
H, 2.57 (2.53).
IR (nujol) cm: /(c=0), 1650; (c=c), 1590; , (c=N), 1505; (Hg-CI), 370.
UV (DMF), nm (log ,):273 (5.6); 244 (3.0).
H NMR (d-dmso), 3.90 (s,3H,1-Me); 3.42 (s, 3H, 3-Me); 3.18 (s, 3H,7-Me); 8.20 (s, 1H,
H(8)); 7.05-8.05 (m, 4H (phenyl)).
3C NMR (dS-dmso), ppm: Caffeine, C(2), 152.0; C(4), 148.3; C(5), 107.3; C(6), 160.8; C(8),
134.4; 1-Me, 26.6; 3-Me, 30.0; 7-Me, 28.5; Phenyl, C(1’), 149.0; C(2’,6’), 141.8; C(3’, 5’),
124.4; C(4’), 135.5.
Evaluation of Anti-Inflammatory Activity. The method of Lakdawala et aL8 based on carrageenan-
induced paw edema in rats was used to evaluate anti-inflammatory activity of the complexes. It
determines the ability of the test compound to inhibit the edema produced by carrageenan in the hind
paw of the rats. Indomethacin was used as a reference.
Group of six rats (Charles Foster variety) were fasted overnight prior to the initiation of he
experiment. Hind paw edema was induced by subcutaneous injection of carrageenan solution (0.1
ml) into the left hind paw of the rats. The right hind paw was injected with carboxymethylcellulose
(CMC, 10 ml Kg), which serves as a control. A suspension of the test compounds (100 mg Kg)
was prepared in aqueous gum tragacanth. The test compounds were administered orally. The
volumes of both the hind paws were determined before and 3 h after the injection of carrageenan,
with the help of mercury plathysmograph attached to Digitlog Recorder through Statham Pressure
Transducer (p230b). Percent inhibition of increase in paw volume was calculated.
RESULTS AND DISCUSSION
Satisfactory results of elemental analysis and spectral studies reveal that the complexes are
of good purity. This is also supported by TLC. The complexes are soluble in THF, DMSO and
acetone. Conductance measurements in 103M solution are of the order of 0.50 ohm cm2 mol,
indicating that the complexes are non-electrolytes.
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Infrared Spectra. Theophylline may chelate to the metal ion through N(7) and exocyclic oxygen at
C(6) or may be bound to the metal ion through N(7) alone3, 9. However, it is not possible to
distinguish between these two binding modes on the basis of IR spectra for the balanced N7/O6
chelation compared with unidentate N7 binding introduces no changes in the 1500-1750 cm
region 10.
For example, in the mercury-theophylline complexes reported by Norris et al. 9, the y (c=0) stretching
frequency in free theophylline absorbed at 1680 and 1720 cm, while in the metal complexes it was
shifted to 1630-1665 cm although the crystal structure data ruled out the involvement in
complexation of the carbonyl group at C(6). In the present theophylline complex too, the band
attributed to the y (c=0) stretching frequency was lowered from 1660 cm to 1630 cm. This shift,
however, cannot be attributed to the interaction of the carbonyl at C(6) with mercury (11) ion, since the
UV and 3C NMR data indicated the non-chelating behaviour of theophylline. In the case of
theobromine and caffeine complexes, the y (c=0) stretching frequency remained unaltered on
complexation. Substantial shift from ca. 1550 cm to ca. 1520 cm were observed for the purine ring
modes10.
UV Spectra. The UV spectra of theophylline, theobromine and caffeine showed an absorption band
at 270 nm (log 7.5), 274 nm (log 6.2) and 272 nm (log 5.8), respectively due to the *
transition of the chromophoric carbonyl group11. In the case of complexes, this absorption occurred
at ca. 272 rim. Since no significant shift was observed in the Xmax value, the possibility of bonding
through carbonyl group was ruled out.
H NMR Spectra. In the H NMR spectra, the theophyllinato group showed no significant shift on
complexation. However in theobromine and caffeine, the signal due to H(8), which absorbed at ca.
8.00 (s, 1H), was shifted to 8.20 on complexation; the downfield shift was attributed to the
involvement of N(9) in complexation.
C NMR Spectra. In the 3C NMR spectra, the signal at ca. 160 ppm in case of free ligands was
attributed to the C(6) carbonyl. Since no significant shift was observed on complexation, it was
concluded that the carbonyl at C(6) was not coordinated to the mercury (11) ion4. However, the
resonance signal due to C(8), which appeared at 140.1 ppm in theophylline, was shifted to 143 ppm
in complex (I), supporting the assertion that complexation involved deprotonation at N(7). Similarly,
in theobromine and caffeine the signal due to C(8) absorbed at ca. 134.5. In complexes (II-IV), this
signal absorbed at ca. 138 ppm, supporting the involvement of N(9) in complexation.
Anti-Inflammatory Activity. The results of anti-inflammatory activity, presented in Table-l, reveal
that at an oral dose of 100 mg kg, the test compounds, (I), (11), (111) and (IV), produced 22, 58, 31
and 61 percent inhibition, respectively.
TABLE I. ANTI-INFLAMMATORY ACTIVITY
Compound Dose
(mg Kg PO)
Edema Inhibition
(ml) (%)
CMC (control) 10 0’88
(I) 100 0.30 22
(11) 100 0.37 58
(111) 100 0.30 31
(IV) 100 0.34 61
Indomethacin 5 0.34 61
/reference/
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The nonsteroidal anti-inflammatory drugs generally possess an aromatic group and/or
heteroaromatic rings (such as purine units) in their structure. From the point of view of the degree of
anti-inflammatory action, two structural aspects are important. Firstly, the presence of chlorine,
fluorine or pseudohalogen equivalents are generally activity enhancing. Secondly, ionic substituents,
such as a nitro group on the aromatic ring of the molecule also enhance the activity13. The presence
of such groups enables the drug to interact with the bi-layer cell membrane14.
In the present study too, the variation in anti-inflammatory activity followed the above criteria.
The complexes, (11) and (IV), which had both a chloro group and a nitro substituent in their
structures, resulted in a significant inhibition of edema. Next in the anti-inflammatory action was the
compound (111) which had a chloro group but no ionic substituent. The complex (I) which had neither
a chloro group, nor an ionic substituent was least active of all the compounds considered in this
investigation.
CONCLUSION
Although the concentration of test samples was different from that of indomethacin
(reference drug), it was possible to make a comparative assessment of the anti-inflammatory activity
o.f the compounds and also to study the variation of biological activity vis-a-vis the nature of
substituents on the complexes.
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